Page results
-
Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning is about to be used for diagnostics in the U.K. thanks to a new partnership between UCLH and Guilford Street Laboratories (GSL).
-
Arif Ahmed is an entrepreneur and private equity investor in healthcare, technology, e-commerce and B2B services companies. He has a proven track record of scaling innovation in complex regulatory environments.
-
Dr Jonathan Broomberg joined the UCLH Board in January 2025 as a non-executive director. He is currently the CEO of Vitality Health International and Global Head of Health Insurance for the Discovery Group, bringing a wealth of experience in the commercial healthcare sector and global public health and policy.
-
Johanna Moss was appointed to the Board on 7 January 2025 as the director of strategy. Prior to this Jo was the chief strategy and transformation officer for the North East London Integrated Care Board and she also held the role of director of strategy and partnerships at Moorfields Eye Hospital NHS Foundation Trust for seven years, where she was the lead for their major capital project to build a new hospital and research centre in Camden.
-
Carlito Adan - Deputy Lead Nurse Clinical Research Facility
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
-
UCLH has recruited the first patient to a global trial of an investigational medication for adults with Huntington’s Disease (HD).
-
Photographs captured during the Black History Month screening on 24th October 2024.
-
Following the successful premiere at Everyman Cinema, Muswell Hill, SICKLE, the groundbreaking documentary on sickle cell disorder, continued its impactful journey with a screening at Ritzy Picture House in Brixton on Thursday 24 October. Held in celebration of Black History Month, the event aimed to raise awareness and educate both healthcare professionals and the public about the realities of living with sickle cell disorder.
-
More than 400 patients at UCLH have so far benefited from an exciting new cancer treatment called proton beam therapy (PBT) – which uses high-energy beams of protons, rather than X-rays, to deliver a dose of radiotherapy.
File results
-
FOI/2022/0048 - Cancer deaths in relation to Covid-19
-
FOI/2022/0069 - Trust’s flexible endoscope inventory
-
FOI/2022/0094 - Emergency Covid funding - private FM contractors
-
FOI/2022/0114 - Number of new diagnoses relating to various conditions
-
FOI/2022/0118 - Contact centre/ Call centre contracts
-
FOI/2022/0150 - Hepatocellular carcinoma drug treatments
-
FOI/2022/0161 - Referral to treatment waiting times
-
FOI/2022/0163 - Ongoing staff absence due to COVID-19
-
FOI/2022/0166 - Routine GP referrals made to Cardiology, Gynaecology and Neurology
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)